SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Calidi's CLD-401 Eradicates Tumors in 80% of Mice in Preclinical Study

Calidi reported that its CLD-401 therapy eradicated tumors in 80% of mice in a preclinical breast cancer study.

CLDI

Related stories